Hemas Holdings PLC

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023-04 to 2024-03🗂️ Report periods on file: 2023-04 to 2024-03, 2022-04 to 2023-03, 2020-04 to 2021-03, 2019-04 to 2020-03, 2018-04 to 2019-03

In its 2023-04 to 2024-03 reporting, Hemas Holdings PLC disclosed greenhouse gas emissions of 16.5K MT. By scope: Scope 1: 2.0K MT; Scope 2: 14.6K MT; Scope 3: 2.0K MT. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
16.5K MT
2023-04 to 2024-03
⚡
Renewable Energy
5%
of total energy
💧
Water Usage
192.6K m3
2023-04 to 2024-03
♻️
Waste
1.6M kg
2023-04 to 2024-03
⚙️
Energy Use
104.4K GJ
2023-04 to 2024-03

📊 Emissions by Scope (2023-04 to 2024-03)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).2.0K MT
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.14.6K MT
Scope 3Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.).2.0K MT

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
2023-04 to 2024-0316.5K MT
2022-04 to 2023-0316.5K MT CO2e/year
2020-04 to 2021-0316.8K tCO2e/year
2019-04 to 2020-0318.9K MT
2018-04 to 2019-0322.0K tCO2e/year

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

📅 Medium-term

  • Reduce water consumption by 50% by 2030
  • Reduce energy consumption by 25% by 2030

🌱 ESG Focus Areas

Environmental Footprint ReductionSocial ImpactCorporate Governance

⚠️ Challenges & Risks +

  • Economic crisis in Sri Lanka impacting consumer spending and purchasing power
  • NMRA mandated price reductions in pharmaceuticals
  • High employee turnover due to economic conditions

📋 Report Information

Reporting Period: 2023-04 to 2024-03
Frameworks: GRI Standards, IFRS S1 and S2, TCFD Recommendations, UN Sustainable Development Goals
Assurance: Ernst & Young